UNDERWRITING AGREEMENTUnderwriting Agreement • May 27th, 2016 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
The undersigned, Intellipharmaceutics International Inc. (the “Company”), hereby confirms its agreement (this “Agreement”) with Dawson James Securities, Inc. (the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
COMMON SHARE PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL Inc.Intellipharmaceutics International Inc. • May 27th, 2016 • Pharmaceutical preparations • New York
THIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on June ___, 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Intellipharmaceutics International Inc., a Canadian corporation (the “Company”), up to ______ common shares of the Company, no par value (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is one of a series of warrants (collectively, the “Warrants”) that were originally issued pursuant to that certain Underwriting Agreement, dated as of May [•], 2016, between the Com
